Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1201913-82-7	Tofogliflozin hydrate CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2.O	C₂₂H₂₈O₇	404.5	98%	Click to inquire
120205-50-7	(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid CC(C(C1CCCN1C(=O)OC(C)(C)C)OC)C(=O)O	C₁₄H₂₅NO₅	287.35	98%	Click to inquire
120205-53-0	(3R,4S,5S)-Tert-butyl 4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate CCC(C)C(C(CC(=O)OC(C)(C)C)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C	C₂₆H₅₁N₃O₅	485.7	98%	Click to inquire
1202055-32-0	N-(2,6-Diethylphenyl)-1-Methyl-8-({4-[(1-Methylpiperidin-4-Yl)carbamoyl]-2-(Trifluoromethoxy)phenyl}amino)-4,5-Dihydro-1h-Pyrazolo[4,3-H]quinazoline-3-Carboxamide CCC1=C(C(=CC=C1)CC)NC(=O)C2=NN(C3=C2CCC4=CN=C(N=C43)NC5=C(C=C(C=C5)C(=O)NC6CCN(CC6)C)OC(F)(F)F)C	C₃₅H₃₉F₃N₈O₃	676.7	99%	Click to inquire
1202402-40-1	Ciforadenant CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5	C₂₀H₂₁N₇O₃	407.4	99%	Click to inquire
1202579-25-6	2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(2-propen-1-yloxy)phenyl]-, (3R,4S)- C=CCOC1=CC=C(C=C1)C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(=O)C4=CC=C(C=C4)F	C₂₇H₂₃F₂NO₃	447.5	98%	Click to inquire
1202916-90-2	(E)-5-chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)C=C4C5=C(C=CC(=C5)Cl)NC4=O	C₂₆H₂₄ClN₃O₃	461.9	99%	Click to inquire
1203656-90-9	4-((6-Chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)-3,5-difluoroaniline C1=C(C=C(C(=C1F)OC2=CC(=NC3=C2C(=CN3)C(F)(F)F)Cl)F)N	C₁₄H₇ClF₅N₃O	363.67	98%	Click to inquire
1204312-39-9	2-Acetamido-4-chloro-5-methylbenzoic acid CC1=CC(=C(C=C1Cl)NC(=O)C)C(=O)O	C₁₀H₁₀ClNO₃	227.64	98%	Click to inquire
120444-05-5	Propanoic acid, 2-(acetyloxy)-, 1,1-dimethylethyl ester, (2S)- CC(C(=O)OC(C)(C)C)OC(=O)C	C₉H₁₆O₄	188.22	98%	Click to inquire

Tofogliflozin hydrate

Tofogliflozin (hydrate)

C₂₂H₂₈O₇ 404.5

(2R,3R)-3-((S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid

(2R,3R)-BOC-dolaproine

C₁₄H₂₅NO₅ 287.35

(3R,4S,5S)-Tert-butyl 4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate

Dov-Val-Dil-OtBu

C₂₆H₅₁N₃O₅ 485.7

N-(2,6-Diethylphenyl)-1-Methyl-8-({4-[(1-Methylpiperidin-4-Yl)carbamoyl]-2-(Trifluoromethoxy)phenyl}amino)-4,5-Dihydro-1h-Pyrazolo[4,3-H]quinazoline-3-Carboxamide

C₃₅H₃₉F₃N₈O₃ 676.7

Triazolo-pyramidine derivative

C₂₀H₂₁N₇O₃ 407.4

2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(2-propen-1-yloxy)phenyl]-, (3R,4S)-

2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(2-propen-1-yloxy)phenyl]-, (3R,4S)-

C₂₇H₂₃F₂NO₃ 447.5

(E)-5-chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one

C₂₆H₂₄ClN₃O₃ 461.9

4-((6-Chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)-3,5-difluoroaniline

Benzenamine, 4-[[6-chloro-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]oxy]-3,5-difluoro-

C₁₄H₇ClF₅N₃O 363.67

2-Acetamido-4-chloro-5-methylbenzoic acid

2-acetamido-4-chloro-5-methylbenzoic acid

C₁₀H₁₀ClNO₃ 227.64

Propanoic acid, 2-(acetyloxy)-, 1,1-dimethylethyl ester, (2S)-

Propanoic acid, 2-(acetyloxy)-, 1,1-dimethylethyl ester, (2S)-

C₉H₁₆O₄ 188.22

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15161) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号